Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
First Patient Enrolled in the US Phase 2 Combination Therapy of Akeso's Ligufalimab with Azacitidine for Myelodysplastic Syndrome 2024-08-06 12:44
OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics 2024-08-06 11:01
Yum China Reports Second Quarter Results 2024-08-06 05:48
Yum China Board Announces CFO Transition and Welcomes New Board Member 2024-08-06 04:30
EarFun's New Premium Flagship Adaptive ANC Wireless Earbuds with Uncompromising Lossless Audio Featuring Auracast™ 2024-08-06 00:00
STRADVISION Accelerates Digital Transformation with New Data Pipeline Automation System 2024-08-05 23:00
Chinese business delegation visits US, both sides agree to boost cooperation 2024-08-05 22:00
Xiao-I Corporation Announces Plan to Implement ADS Ratio Change 2024-08-05 21:58
META Pharmaceuticals announces FDA Grants Rare Pediatric Disease Designation to META-001-PH for the Treatment of Primary Hyperoxaluria 2024-08-05 21:52
Silicon Motion Launches the Best Performance/Watt PCIe Gen5 SSD Controller at FMS 2024 2024-08-05 21:00
VSPO Chairman Dino Ying Named Vice President of Global Esports Federation 2024-08-05 20:36
Celebrating Speediance's 4th Anniversary: Revolutionizing the Fitness Industry 2024-08-05 20:00
Antennova Announces CD73 Small Molecule Inhibitor Accepted for Mini Oral Presentation at ESMO Congress 2024 2024-08-05 20:00
QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER 2024-08-05 19:00
JinkoSolar Announces Cash Dividend 2024-08-05 18:00
So-Young to Report Second Quarter 2024 Financial Results on August 23, 2024 2024-08-05 17:00
Viomi Technology Co., Ltd to Report First Half 2024 Financial Results on Monday, August 26, 2024 2024-08-05 17:00
NetEase to Report Second Quarter 2024 Financial Results on August 22 2024-08-05 16:30
Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Ocular Surgery Relief and Recovery 2024-08-05 16:30
Youdao to Report Second Quarter 2024 Financial Results on August 22 2024-08-05 16:30
1 58 59 60 61 62 6579